Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.
Guido V Bloemberg, Peter M Keller, David Stucki, David Stuckia, Andrej Trauner, Sonia Borrell, Tsogyal Latshang, Mireia Coscolla, Thomas Rothe, Rico Hömke, Claudia Ritter, Julia Feldmann, Bettina Schulthes... more s, Sebastien Gagneux, and Erik C Böttger. less
University of Zurich, Zurich, Switzerland.
N. Engl. J. Med. 2015 Nov 12; 373 (20): 1986-8.
AbstractTreatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.